Problems falling asleep
Thoughts that keep running in bed at night, not finding calm, lying awake for one to two hours instead of falling asleep.
Cureal treatment spectrum
Sleep disorders affect falling asleep, staying asleep or how restorative sleep is, and are among the most common health complaints in Germany. Cureal assesses medical cannabis medically as a possible complementary treatment option.
Context
Sleep disorders are not a single clinical picture but an umbrella term for complaints affecting falling or staying asleep, sleep quality or the sleep-wake rhythm. The S3 guideline "Unrefreshing sleep, sleep disorders" of the German Sleep Society provides the methodological framework. According to data from the Robert Koch Institute, about a quarter of adults in Germany report long-lasting sleep problems, women more often than men.
The main forms include problems falling and staying asleep (insomnia), sleep-related breathing disorders such as sleep apnoea, hypersomnias with an increased need for sleep during the day, disorders of the sleep-wake rhythm, parasomnias such as nightmares or sleepwalking, and sleep-related movement disorders such as restless legs syndrome.
Daytime tiredness, drops in concentration and performance, irritability, low mood and an increased cardiovascular risk often shape the everyday lives of those affected. A precise diagnosis and a sleep diary help with planning therapy.
Symptom areas
Sleep disorders differ from person to person. These points do not replace a diagnosis but help with an initial assessment.
Thoughts that keep running in bed at night, not finding calm, lying awake for one to two hours instead of falling asleep.
Waking several times during the night, difficulty getting back to sleep, not waking up rested in the morning.
Waking too early can be linked to stress, depression, pain or an unstable sleep-wake rhythm.
Poor concentration, irritability and a constant struggle against feeling foggy during the day are warning signs to take seriously.
Rumination, stress and a raised level of arousal before going to bed are common triggers, but not the only cause.
Snoring with pauses in breathing, restless legs, severe daytime sleepiness or new neurological symptoms must be investigated.
Diagnostic work-up
Sleep disorders are not identified by a blood test but assessed through the medical history, a sleep diary and standardised questionnaires.
A sleep medicine assessment begins with a medical history interview and a sleep diary kept for two to four weeks. Standardised questionnaires such as the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale help to assess severity and daytime symptoms.
If a breathing disorder is suspected or the cause is unclear, polysomnography in a sleep laboratory is the next step. A reliable diagnosis of the form and the underlying causes is a prerequisite for using cannabis therapy in a targeted way. Cureal works in coordination with your GP or sleep medicine practice.
Conventional treatment
Treatment follows the S3 guideline and has several layers. Medical cannabis complements these building blocks for persistent complaints but does not replace them.
A consistent sleep-wake rhythm, less screen time in the evening, no caffeine after midday and a cool, quiet sleeping environment form the basis of sleep hygiene. Cognitive behavioural therapy for insomnia (CBT-I) is considered the first-line therapy for chronic insomnia and, according to the research, has longer-lasting effects than sleeping pills.
First line according to the S3 guidelineIf basic therapy alone is not enough, further options may be considered depending on the cause:
Cannabis and sleep
The endocannabinoid system is involved in regulating sleep and wakefulness, in stress processing and in pain perception. Cannabis compounds such as THC and CBD act on the same receptors in the body, which is why they are discussed for sleep complaints, especially when restlessness or pain disturbs sleep.
Cannabidiol (CBD) is not psychoactive and is associated with anxiety-relieving, calming and sleep-promoting effects. The review by Babson, Sottile and Morabito (2017) describes improved sleep quality under CBD, above all in connection with anxiolytic effects.
At a low dose, tetrahydrocannabinol (THC) can shorten the time it takes to fall asleep and support deep sleep phases, as a study by Vaughn and Carter (2010) shows. Doses that are too high can shorten REM sleep phases and cause tiredness the next day. THC-containing medications are therefore started at a low dose in the evening and adjusted following the principle "start low, go slow", often in combination with CBD.
Evidence
Compared with chronic pain or epilepsy, the research is still being built up, but it provides consistent indications of positive effects, above all with accompanying tension and pain-related problems staying asleep. As early as 2010, Vaughn and Carter studied the use of cannabinoids in chronic insomnia and described improvements in the time taken to fall asleep and in subjective sleep quality.
One of the most cited syntheses on cannabinoids and sleep describes improved sleep quality under CBD, above all with tension and anxiety, and a shorter time to fall asleep under low-dose THC. High doses of THC can reduce the REM phase.
The analysis summarises the state of knowledge on the effect of cannabinoids on sleep and describes improvements in insomnia, pain-related sleep problems and anxiety- or stress-related accompanying symptoms. Standardised randomised studies remain necessary.
Legal situation
Access to medical cannabis is considerably easier today than it was only a few years ago. Medical cannabis has been available on prescription in Germany since 2017, and the change in the law in 2024 made access easier still for patients.
There is no approved finished cannabinoid medicine for sleep disorders. It is used exclusively outside its approved indication (off-label), based on an individual medical decision. Cost coverage by German statutory health insurance is assessed case by case, but is rare for isolated sleep disorders without another serious illness. Most patients pay for cannabis therapy privately.
Process
The decision for or against cannabis therapy is always made by the treating doctor in the individual appointment.
Your sleep history, previous treatment attempts and accompanying factors such as pain, tension or low mood are discussed, and the entire medication plan is checked for interactions.
The doctor assesses whether cannabis therapy is medically justifiable for the individual form of sleep disorder, complemented by a prior sleep medicine assessment if appropriate.
If the indication is suitable, the doctor issues a private prescription. The active substance, usually CBD-dominant for day and evening, optionally a THC-containing medication for falling asleep, and the dosage form are determined individually.
We send the prescription to your preferred pharmacy. Treatment starts at low doses following the principle "start low, go slow".
After two to four weeks the doctor reviews how the time taken to fall asleep, waking at night and daytime tiredness have developed. Dose and strain are adjusted if needed.
Context
There is no standardised cannabis medication for sleep disorders as a routine therapy. The active substance, dose and time of intake are therefore aligned particularly closely with the cause, the sleep goal and how you function in the morning.
Frequently asked questions
These answers give you initial orientation. The specific assessment for the individual situation is made by the treating doctor.
In many patients with persistent sleep disorders, medical cannabis can make it easier to fall asleep, reduce waking at night and ease inner restlessness before going to bed. The effect varies from person to person and depends on the choice of active substance, the dosage and the underlying cause. Cannabis is most likely to work where tension, pain or anxiety disturb sleep.
The choice is made individually in the initial consultation. CBD-dominant medications are used during the day and in the evening because they are not psychoactive and are easy to adjust, above all for inner restlessness and rumination. THC-containing medications for falling asleep are started at a low dose in the evening, because doses that are too high can cause tiredness the next day. Combination products with a balanced THC-CBD ratio are in many cases the practical solution.
No. Sleep hygiene, cognitive behavioural therapy for insomnia and treatment of the underlying causes remain the basis. Medical cannabis can be considered as a complement for persistent complaints in individual cases, but does not replace these building blocks.
With medical cannabis prescribed by a doctor at a therapeutic dose, the potential for physical dependence is considerably lower than with benzodiazepines or Z-drugs. Psychological habituation is possible, above all with long-term use without medical supervision. Particular caution is needed with a current or past addiction.
THC-containing medications usually work on the day they are first taken, and the right evening dose is titrated over two to four weeks. CBD-dominant medications take somewhat longer: an initial response usually appears after a few days to two weeks, and full adjustment generally takes four to six weeks.
Possible side effects are a dry mouth, tiredness the next day, above all if the evening dose of THC is too high, mild dizziness and a temporarily faster heartbeat, especially during the adjustment phase. In patients with sleep problems, the doctor also monitors whether daytime tiredness decreases and the ability to concentrate is maintained.
With medical cannabis prescribed by a doctor you are generally allowed to drive, provided you are fit to drive and the therapy is stably adjusted. At the start of therapy and after dose adjustments, reaction time in the morning may be reduced. Recommendation: do not drive yourself during the first days of adjustment.
Related topics
Sleep disorders often occur together with other conditions. These topics are closely linked.
Pain-related problems staying asleep often disappear once pain therapy takes effect. Cannabis can address both levels at the same time.
Go to pageSleep disorders and depressive episodes often reinforce each other and should be treated in parallel.
Go to pageInner restlessness and anxiety are among the most common drivers of insomnia. Cannabis therapy can have an effect on both areas.
Go to pageIf distressing sleep problems persist despite investigation of the cause, sleep hygiene or CBT-I, a medical consultation can clarify whether medical cannabis is justifiable for the individual situation.